CXSB2100011 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(原7) | Supplementary Application | 2021-02-06 | 信立泰(成都)生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | In Review | 2021-02-05 | view |
CXSB2100010 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(原7) | Supplementary Application | 2021-02-06 | 信立泰(成都)生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | In Review | 2021-02-05 | view |
CXSL1700158 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(7) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |
CXSL1700157 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(1) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |
CXSL1700159 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(7) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |